BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 34211801)

  • 21. Elevated ATP via enhanced miRNA-30b, 30c, and 30e downregulates the expression of CD73 in CD8+ T cells of HIV-infected individuals.
    Shahbaz S; Okoye I; Blevins G; Elahi S
    PLoS Pathog; 2022 Mar; 18(3):e1010378. PubMed ID: 35325005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myeloma escape after stem cell transplantation is a consequence of T-cell exhaustion and is prevented by TIGIT blockade.
    Minnie SA; Kuns RD; Gartlan KH; Zhang P; Wilkinson AN; Samson L; Guillerey C; Engwerda C; MacDonald KPA; Smyth MJ; Markey KA; Vuckovic S; Hill GR
    Blood; 2018 Oct; 132(16):1675-1688. PubMed ID: 30154111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delayed Expression of PD-1 and TIGIT on HIV-Specific CD8 T Cells in Untreated HLA-B*57:01 Individuals Followed from Early Infection.
    Scharf L; Tauriainen J; Buggert M; Hartogensis W; Nolan DJ; Deeks SG; Salemi M; Hecht FM; Karlsson AC
    J Virol; 2020 Jul; 94(14):. PubMed ID: 32350076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological blockade of the CD39/CD73 pathway but not adenosine receptors augments disease in a humanized mouse model of graft-versus-host disease.
    Geraghty NJ; Watson D; Sluyter R
    Immunol Cell Biol; 2019 Jul; 97(6):597-610. PubMed ID: 30957314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased PD-1+Tim-3+ exhausted T cells in bone marrow may influence the clinical outcome of patients with AML.
    Tan J; Yu Z; Huang J; Chen Y; Huang S; Yao D; Xu L; Lu Y; Chen S; Li Y
    Biomark Res; 2020; 8():6. PubMed ID: 32082573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations in CD39/CD73 axis of T cells associated with COVID-19 severity.
    Dorneles GP; Teixeira PC; da Silva IM; Schipper LL; Santana Filho PC; Rodrigues Junior LC; Bonorino C; Peres A; Fonseca SG; Monteiro MC; Boeck CR; Eller S; Oliveira TF; Wendland EM; Romão PRT
    J Cell Physiol; 2022 Aug; 237(8):3394-3407. PubMed ID: 35754396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defining the CD39/CD73 Axis in SARS-CoV-2 Infection: The CD73
    Ahmadi P; Hartjen P; Kohsar M; Kummer S; Schmiedel S; Bockmann JH; Fathi A; Huber S; Haag F; Schulze Zur Wiesch J
    Cells; 2020 Jul; 9(8):. PubMed ID: 32707842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PD-1
    Liu X; Li M; Wang X; Dang Z; Jiang Y; Wang X; Kong Y; Yang Z
    Cancer Immunol Immunother; 2019 Dec; 68(12):2041-2054. PubMed ID: 31720814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory Molecules PD-1, CD73 and CD39 Are Expressed by CD8
    Smith CJ; Snyder CM
    Front Immunol; 2021; 12():704862. PubMed ID: 34335618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD26
    Zhou H; Jia B; Annageldiyev C; Minagawa K; Zhao C; Mineishi S; Ehmann WC; Naik SG; Cioccio J; Wirk B; Songdej N; Rakszawski KL; Nickolich MS; Shen J; Zheng H
    Front Immunol; 2023; 14():1169144. PubMed ID: 37457737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ex vivo isolation, expansion and bioengineering of CCR7+CD95-/or CD62L+CD45RA+ tumor infiltrating lymphocytes from acute myeloid leukemia patients' bone marrow.
    Cao H; Kim DH; Howard A; Moz H; Wasnik S; Baylink DJ; Chen CS; Reeves ME; Mirshahidi S; Xiao J; Francis O; Marcucci G; Xu Y
    Neoplasia; 2021 Dec; 23(12):1252-1260. PubMed ID: 34775232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of mRNA Expressions of TOX and NR4As in CD8+ T cells in Acute Leukemia.
    Mohammadi M; Asgarian-Omran H; Najafi B; Najafi A; Valadan R; Karami H; Naderisoraki M; Alizadeforoutan M; Shekarriz R; Tehrani M
    Iran J Immunol; 2023 Dec; 20(4):438-445. PubMed ID: 37961948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered CD39 and CD73 Expression in Rheumatoid Arthritis: Implications for Disease Activity and Treatment Response.
    Ortiz MA; Diaz-Torné C; De Agustin JJ; Estrada P; Reina D; Hernandez MV; Sang H; Zamora C; Cantó E; Corominas H; Vidal S
    Biomolecules; 2023 Dec; 14(1):. PubMed ID: 38275742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice.
    Covarrubias R; Chepurko E; Reynolds A; Huttinger ZM; Huttinger R; Stanfill K; Wheeler DG; Novitskaya T; Robson SC; Dwyer KM; Cowan PJ; Gumina RJ
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1809-20. PubMed ID: 27417582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inversed Ratio of CD39/CD73 Expression on γδ T Cells in HIV Versus Healthy Controls Correlates With Immune Activation and Disease Progression.
    Kolbe K; Wittner M; Hartjen P; Hüfner AD; Degen O; Ackermann C; Cords L; Stellbrink HJ; Haag F; Schulze Zur Wiesch J
    Front Immunol; 2022; 13():867167. PubMed ID: 35529864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TIGIT Expression Delineates T-cell Populations with Distinct Functional and Prognostic Impact in Pancreatic Cancer.
    Heiduk M; Klimova A; Reiche C; Digomann D; Beer C; Aust DE; Distler M; Weitz J; Seifert AM; Seifert L
    Clin Cancer Res; 2023 Jul; 29(14):2638-2650. PubMed ID: 37140899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenosine Generated by Regulatory T Cells Induces CD8
    Shi L; Feng M; Du S; Wei X; Song H; Yixin X; Song J; Wenxian G
    Biomed Res Int; 2019; 2019():4093214. PubMed ID: 31930120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased TOX expression concurrent with PD-1, Tim-3, and CD244 in T cells from patients with non-Hodgkin lymphoma.
    Huang S; Liang C; Zhao Y; Deng T; Tan J; Lu Y; Liu S; Li Y; Chen S
    Asia Pac J Clin Oncol; 2022 Feb; 18(1):143-149. PubMed ID: 33608984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD73-mediated adenosine production promotes stem cell-like properties in mouse Tc17 cells.
    Flores-Santibáñez F; Fernández D; Meza D; Tejón G; Vargas L; Varela-Nallar L; Arredondo S; Guixé V; Rosemblatt M; Bono MR; Sauma D
    Immunology; 2015 Dec; 146(4):582-94. PubMed ID: 26331349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LIGHT (TNFSF14) Costimulation Enhances Myeloid Cell Activation and Antitumor Immunity in the Setting of PD-1/PD-L1 and TIGIT Checkpoint Blockade.
    Yoo KJ; Johannes K; González LE; Patel A; Shuptrine CW; Opheim Z; Lenz K; Campbell K; Nguyen TA; Miriyala J; Smith C; McGuire A; Tsai YH; Rangwala F; de Silva S; Schreiber TH; Fromm G
    J Immunol; 2022 Aug; 209(3):510-525. PubMed ID: 35817517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.